|
FBXO9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
8.6084999995073E-07 |
| Normal-vs-Stage3 |
1.75189973639078E-10 |
| Normal-vs-Stage4 |
5.40678612992451E-14 |
| Stage1-vs-Stage2 |
9.970400E-01 |
| Stage1-vs-Stage3 |
1.627970E-01 |
| Stage1-vs-Stage4 |
2.380400E-02 |
| Stage2-vs-Stage3 |
2.981400E-01 |
| Stage2-vs-Stage4 |
1.479640E-01 |
| Stage3-vs-Stage4 |
5.820000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.237330E-04 |
| Normal-vs-Asian |
1.073650E-02 |
| Caucasian-vs-AfricanAmerican |
1.220360E-01 |
| Caucasian-vs-Asian |
6.941600E-01 |
| AfricanAmerican-vs-Asian |
4.743200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
8.06840150247012E-11 |
| Male-vs-Female |
1.392370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.96964666798749E-12 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
1.85162996046984E-12 |
| Normal-vs-Extreme_Obese |
1.181590E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.730800E-01 |
| Normal_Weight-vs-Obese |
2.303200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.349000E-01 |
| Extreme_Weight-vs-Obese |
6.526300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.732200E-01 |
| Obese-vs-Extreme_Obese |
4.223800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.60329999966092E-08 |
| Normal-vs-Age(41-60Yrs) |
6.52989884386557E-11 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.54967999999034E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.377840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.107600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.735360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.770100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.591900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.033570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62825308791525E-12 |
| Normal-VS-Type2 PRCC |
1.62436730732907E-12 |
| Normal-VS-KIRP CIMP |
4.2592000000008E-05 |
| Normal-VS-Unclassified PRCC |
1.41299999478761E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.859700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.745800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.968800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.485800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.447770E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.940400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62436730732907E-12 |
| Normal-vs-N1 |
1.055970E-01 |
| Normal-vs-N2 |
1.16462395283179E-13 |
| N0-vs-N1 |
3.099800E-01 |
| N0-vs-N2 |
3.53000000341552E-08 |
| N1-vs-N2 |
6.844700E-03 |
|
|
